Observational studyJAMA network open2025

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma.

Lina Camacho-Arteaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.